Active ingredientTacrineCat. No. P-T003-001CAS 321-64-2Family · Pharmaceutical analytical standards
Tacrine
An acetylcholinesterase inhibitor that raises acetylcholine levels in the brain: in 1993 it became the first drug approved by the FDA for Alzheimer's disease, paving the way for later treatments. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It had been synthesised as early as 1949 by the chemist Adrien Albert at the University of Sydney, more than forty years before it became a medicine for memory.
Go to the active ingredient →Active ingredientTacrineCat. No. P-T003-001CAS 321-64-2
Isotopically labelled1-Hydroxy Tacrine-d4Cat. No. P-T003-002CAS 1246911-78-3
Isotopically labelled1-Hydroxy Tacrine-d4 HClCat. No. P-T003-003CAS 1246816-08-9
Impurity1-Hydroxy TacrineCat. No. P-T003-004CAS 124027-47-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.